MoneyWorks4Me

Ambalal Sarabhai Enterprises submits newspaper clippings

01 Jun 2023 Evaluate

Ambalal Sarabhai Enterprises has informed that in compliance with Regulation 30 & 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, it has enclosed the copies of Newspaper Clippings of the publication of the Extract of the Audited Financial Results (Standalone and Consolidated) for the Quarter and Year ended on March 31, 2023 published in Business Standard (English) & Jay Hind (Gujarati) - Ahmedabad on June 1, 2023.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..